Sniper Medical Technology Co Ltd, a company in SIP, recently received the approval from the National Medical Products Administration of China for the market launch of its innovative digital PCR system which is primarily used for quantitative detection of leukemia fusion gene RNA from human blood samples.

Based on Sniper’s proprietary microdroplet generation method, the digital PCR system is the first all-in-one digital PCR system without micro-fluidic chip. The system and related reagent has received the CE marking from the European Union and the certification of the US Food and Drug Administration (FDA) in 2022 and 2023.

The product can help reduce detection cost and improve detection efficiency and accuracy.

June 24, 2025